Powering Partnerships to Propel the RNA Pipeline in North America
Together, We Connect, Collaborate, and Catalyze Change in RNA Medicines
RNA Breakthroughs Start with Great Conversations
From targeted one-on-one partnering sessions to dynamic scientific exchanges, every interaction at RNA Leaders USA catalyzes meaningful collaborations in the RNA therapeutics and vaccines landscape. Immerse yourself in a specialized ecosystem where leading researchers, investors, and executives forge the partnerships driving tomorrow's breakthroughs.
Forge RNA Partnerships Strategically
Expand your RNA therapeutics network effortlessly with PartneringOne, our exclusive platform designed to connect you with pioneering RNA researchers, investors, and industry leaders.
Schedule targeted 1-on-1 meetings with decision-makers advancing the RNA revolution and position yourself at the forefront of next-generation RNA therapeutic development.
Where Innovation and Strategic Solutions Converge
Access top nucleic acid drug developers and pharma leaders in an exclusive setting amongst your CEO peers to walk away with actionable strategies for your mRNA and short RNA business development.
Gain critical insights on oligo-based medicine and mRNA therapeutic valuation processes, IP protection, and identify the ideal industry partners for your RNA platform.
Inspiring Women in RNA Science
Celebrate the groundbreaking achievements of women in nucleic acid therapeutics and vaccines. Connect with a supportive community of visionary researchers, executives, and allies collectively advancing the RNA landscape.
Join the network of exceptional women whose discoveries and leadership are revolutionizing RNA medicine and shaping the future of precision therapeutics.
Witness history in the making as groundbreaking RNA therapies reshape medicines!
Our expert-led presentations, interactive panels, and specialized workshops are all designed to address the industry's most pressing challenges: whether you're advancing mRNA vaccines, developing novel RNA cell therapies, innovating delivery platforms for oligonucleotides or pioneering the next generation of microRNA technologies, our comprehensive program provides the connections, insights, and learning opportunities to propel your work forward.
mRNA Vaccine & Therapeutics
- Clinical data beyond infectious disease areas, such as oncology & rare diseases
- Evaluate mRNA 2.0 modalities – circular RNAs, self-amplifying RNAs and self-replicating RNAs.
Oligo-Based RNA Therapeutics
- Development of ASOs and siRNA into the clinic
- Improve understanding of neurological cardiometabolic and rare diseases
Next-Gen RNA
- RNA editing and RNA cell therapy applications
- Evaluate POCs of regRNAs, tRNAs and other non-coding
- Re-emergence of microRNAs applications
The 2025 RNA Speaker Lineup Keeps Growing
Get to know the latest confirmed speakers joining the 2025 stage.
RNA Leaders USA ... The Numbers
350+
Attendees
70+
Speakers
20+
Partnering Hours
RNA Leaders USA Keynotes Shoutouts: Insights into the Future of RNA Medicine
Scaling Oligo-based Therapeutics with Innovation at the forefront
Featuring
- Paul Nioi, SVP, Research, Alnylam
- Tao Pei, PhD, Senior Vice President, Chemistry, Arrowhead Pharmaceuticals
- Alison Moore, Chief Technical Officer, Codexis
- James Powell, VP RNAi CMC, Boulder Site Head, Novo Nordisk
Enhancing Production and Manufacturing Methods For mRNA-Based Vaccines – Challenges and Future Directions
Featuring
- Shyham Subramanian, VP, Technical Development and CMC Strategy, Moderna
- Patrick Thiaville, VP, 4basebio
- Thaminda Ramanayake, CBO, CureVac
- Miroslav Gasparek, CEO, Senisble Biotechnologies
Bridging the Gap: Addressing Regulatory Challenges in Oligonucleotide Development
Featuring
- Dmitry Samarsky, Chief Technology Officer, Galconda Therapeutics
- Fred Fleitz, Group Vice President, CMC, Arrowhead Pharmaceuticals
- YanLing He, Executive Director in Translational Medicine, Novartis
- Bao Cai, PhD, Executive Director, Process Development, Sarepta Therapeutics
Progressing mRNA-based Therapeutics and Vaccines to Combat Cancer
Featuring
- Anna-Rose Welch, Editorial and Community Director, Advancing RNA, Life Science Connect
- Thaminda Ramanayake, CBO, CureVac
- Daniel Getts, CEO, Myeloid Therapeutics
- Sally Werner, CEO, Cancer Support Community
Thank You to our Community Partners
Your Pass. Your Experience.
RNA Leaders drives the future of RNA development by bringing together the most innovative companies with the right partners.
Attend As A Delegate
- Examine new data & case studies
- Hear the latest innovation
- Connect through one-to-one meetings
Present Your Company
- Increase your visibility
- Showcase your innovations
- Attract new partners
Join As An Investor
- Receive a complimentary registration
- Understand the latest developments
- Find new investment opportunities
Be the First to Know
Melissa Moore
CSO
Moderna
"A really great place to connect with and network with my peers"
Engage Quality Decision-Makers at RNA Leaders USA!
Whether you're looking to generate quality leads, showcase thought leaders, or reinforce your brand, collaborate with us to identify custom sponsorship opportunities to help you reach your business objectives.
Contact us to begin customizing your event presence today:
Companies #, A-F: Jennifer Wickett, JWickett@informaconnectls.com
Companies G-Z: Michael Moriarty, MMoriarty@informaconnectls.com